Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 29200.25 Crore) operating in Pharmaceuti...

Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 27073.29 Crore) operating in Pharmaceuti...

Promoters held 51.83 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.43 per cent, DIIs 16.55 per cent.

Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company's second quarter performance was subdued, mainly ...

"Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Company’s growth journey since inception. A v...

The brokerage believes earnings growth beyond FY21 would remain challenging given limited growth drivers and doubling of R&D.

The analyst suggested a stoploss at Rs 447.

Shrikant Chouhan recommended to keep stoploss at Rs 483.

Buy Aurobindo Pharma Ltd. at a price target of Rs 750.0 and a stoploss at Rs 725 from entry point.

Buy Aurobindo Pharma Ltd. at a price target of Rs 880.0 and a stoploss at Rs 790 from entry point.

Buy Aurobindo Pharma Ltd. at a price target of Rs 825.0 and a stoploss at Rs 775 from entry point.

Buy Aurobindo Pharma Ltd. at a price target of Rs 630.0 and a stop loss at Rs 610 from the entry point.

Sell Aurobindo Pharma Ltd. at a price target of Rs 568.0 and a stop loss at Rs 585 from entry point.

Buy Aurobindo Pharma Ltd. at a price target of Rs 610.0 and a stop loss at Rs 574 from entry point.

Buy Aurobindo Pharma Ltd. at a price target of Rs 722.0 and a stoploss at Rs 668 from entry point.

Buy Aurobindo Pharma at a price target of Rs 850 and a stop loss at Rs 750 from the entry point.

Buy Aurobindo Pharma at a price target of Rs 785 and a stop loss at Rs 732 from entry point.